ctrl K

AI Score

Unlock

Verve Therapeutics Inc. (VERV)

AI Score

Unlock

3.58

-0.27 (-6.89%)

At close: Apr 04, 2025, 3:59 PM

3.57

-0.26%

After-hours: Apr 04, 2025, 04:31 PM EDT

Verve Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	172.56M	206.18M	115.41M	64.33M	8.99M	2.99M
Short-Term Investments	351.72M	417.77M	439.4M	296.11M	63.12M	15.8M
Long-Term Investments	n/a	n/a	4.82M	5.24M	463K	235K
Other Long-Term Assets	7.92M	6.94M	585K	2.7M	n/a	n/a
Receivables	3.25M	5.9M	1.01M	n/a	n/a	n/a
Inventory	n/a	n/a	1.00	n/a	n/a	n/a
Other Current Assets	15.21M	8.1M	7.34M	6.69M	n/a	n/a
Total Current Assets	542.75M	637.95M	563.16M	367.13M	73.97M	19.05M
Property-Plant & Equipment	96.73M	107.8M	110.66M	9.06M	3.98M	2.36M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	104.64M	114.74M	116.06M	17M	4.45M	2.59M
Total Assets	647.39M	752.69M	679.22M	384.12M	78.41M	21.65M
Account Payables	4.52M	6.64M	2.42M	7.08M	36K	2.41M
Deferred Revenue	3.6M	n/a	20.01M	-12.99M	90K	31K
Short-Term Debt	10.44M	n/a	11.9M	1.96M	n/a	n/a
Other Current Liabilities	24.34M	12.34M	-261K	4.99M	n/a	487K
Total Current Liabilities	42.91M	37.01M	35.09M	22.02M	7.32M	3.55M
Long-Term Debt	59.54M	n/a	n/a	n/a	125.16M	35.05M
Other Long-Term Liabilities	51.54M	2.91M	3.17M	4.75M	9.72M	2.46M
Total Long-Term Liabilities	111.08M	116.18M	93.2M	4.75M	135.01M	37.65M
Total Liabilities	153.99M	153.19M	128.29M	26.77M	142.32M	41.2M
Total Debt	69.98M	74.91M	81.92M	1.96M	125.16M	35.05M
Common Stock	89K	82K	62K	49K	3K	2K
Retained Earnings	-743.01M	-544.3M	-344.24M	-186.85M	-66.54M	-20.83M
Comprehensive Income	428K	272K	-694K	-228K	8K	9K
Shareholders Equity	493.4M	599.5M	550.93M	357.35M	-63.91M	-19.55M
Total Investments	351.72M	417.77M	439.4M	296.11M	63.12M	15.8M